Medicines New Zealand - Latest News [Page 5]
Bottleneck in Medicines Access
Friday, 25 November 2011, 3:42 pm | Medicines New Zealand
Debate about the optimal level of medicines access for New Zealand patients has received a substantial contribution from internationally respected health economic analysts. New Zealand patients have been receiving access to new medicines at about half the ... More >>
Standard Clinical Trial Research Agreement Welcomed
Friday, 16 September 2011, 12:38 pm | Medicines New Zealand
Time, money and manpower will be saved by a new, standardised Clinical Trial Research Agreement. Released by the NZ Association for Clinical Research (NZACRES), this standardised contract has been developed for use by sponsors and clinical trials sites. More >>
NZ Medicines Formulary to Benefit Health Professionals
Monday, 12 September 2011, 3:18 pm | Medicines New Zealand
“Health professionals and patients are set to benefit from the introduction of a New Zealand Medicine’s Formulary,” Medicines New Zealand General Manager Kevin Sheehy says. Announced recently by Associate Health Minister Peter Dunne, the Formulary ... More >>
Government Response to Clinical Trials Report Welcomed
Wednesday, 7 September 2011, 12:35 pm | Medicines New Zealand
The Government’s response to the recently published Health Select Committee Report into Clinical Trials has been welcomed by Medicines New Zealand. More >>
Outstanding Research Recognised by Value of Medicines Award
Tuesday, 28 June 2011, 4:50 pm | Medicines New Zealand
Professor Ian Reid of The University of Auckland has received the inaugural Medicines New Zealand Value of Medicines Award. More >>
Joint Regulatory Agency Welcomed by Medicines New Zealand
Monday, 20 June 2011, 3:43 pm | Medicines New Zealand
“A combined trans-Tasman medicines regulatory agency is good news for patients,” Medicines New Zealand General Manager Kevin Sheehy says. More >>
Funding of Innovative Medicine Welcomed
Tuesday, 14 June 2011, 1:33 pm | Medicines New Zealand
PHARMAC’s decision to fund a new type of innovative anti-blood clotting treatment has been welcomed by Medicines New Zealand. More >>
Medicines Industry Welcomes Clinical Trials Report
Wednesday, 8 June 2011, 1:31 pm | Medicines New Zealand
“As the industry association representing innovative pharmaceutical companies in New Zealand we believe the Committee has correctly identified the sense of urgency required if this country is to retain a competitive edge in clinical research,” ... More >>
Medicines New Zealand Welcomes Extra Medicines Investment
Thursday, 19 May 2011, 4:57 pm | Medicines New Zealand
“Increased funding for medicines in this year’s budget will be welcomed by patients, their families and health professionals,” Medicines New Zealand General Manager Kevin Sheehy says. More >>
Entries for Value of Medicines Award are now open
Friday, 29 April 2011, 10:56 am | Medicines New Zealand
"This $20,000 award recognises one New Zealand researcher or health care professional for their outstanding contribution to improving the understanding, effectiveness or safety of the use of medicines," Medicines New Zealand Acting Chief Executive ... More >>
Medicines NZ Welcomes Fourth TPP Negotiation Round
Monday, 6 December 2010, 3:19 pm | Medicines New Zealand
Medicines New Zealand is closely following the fourth round of negotiations for the Trans Pacific Partnership (TPP) being held in Auckland this week. “As the organisation representing innovative pharmaceutical companies in New Zealand we hope that the ... More >>
New Code of Practice for Prescription Medicine
Friday, 1 October 2010, 1:01 pm | Medicines New Zealand
A new Code of Practice to guide the marketing of prescription medicines in New Zealand has been released today. Published and administered by industry organisation Medicines New Zealand, this important self regulation reflects the high level of ethics and ... More >>
Greater access to innovative medicines
Wednesday, 29 September 2010, 1:01 pm | Medicines New Zealand
Greater access to innovative medicines could improve the quality of life for thousands of New Zealanders with Rheumatoid Arthritis (RA). More >>
